TABLE 1.
Characteristics derived from medical records of patients with yeasts in respiratory cultures
| Characteristica | No. (%) of patients in:
|
|
|---|---|---|
| Full ID group | Limited ID group | |
| No. of patients | 267 (100) | 77 (100) |
| Age >60 yr | 148 (55.4) | 46 (60.0) |
| Female | 126 (47.2) | 41 (53.2) |
| Coexisting conditions | ||
| COPD | 97 (36.3) | 35 (45.5) |
| CAD | 67 (25.1) | 32 (41.6) |
| HTN | 85 (31.8) | 23 (29.9) |
| DM | 47 (17.6) | 15 (19.5) |
| Immunocompromised state | 23 (8.6) | 11 (14.3) |
| HIV or AIDS | 9 (3.4) | 4 (5.2) |
| Immunosuppressive therapy | 6 (2.2) | 2 (2.6) |
| Transplantation | 4 (1.5) | 0 (0) |
| Neutropenia | 4 (1.5) | 4 (5.2) |
| Diagnosis upon admission | ||
| Pneumonia | 139 (52.1) | 42 (54.5) |
| Other than pneumonia | 128 (47.9) | 35 (45.5) |
| Nosocomial pneumonia | 33 (12.4) | 11 (14.3) |
| Specimen type | ||
| Sputum (self-expectorated) | 164 (61.4) | 44 (57.1) |
| PBS | 7 (2.6) | 3 (3.9) |
| BAL | 65 (24.3) | 28 (36.4) |
| Induced sputum | 2 (0.7) | 1 (1.3) |
| Mechanical ventilation | 80 (30.0) | 20 (26.0) |
| Side effects of antifungal agents | 7 (2.6) | 2 (2.6) |
| Candidemia | 7 (2.6) | 0 (0) |
| Outcome | ||
| Recovery | 217 (81.3) | 66 (85.7) |
| Deathb | 50 (18.7) | 11 (14.3) |
| Cause of death | ||
| Pneumonia | 19/50 (38.0) | 6/11 (54.5) |
| Other than pneumonia | 31/50 (62) | 5/11 (45.4) |
a
Abbreviations: COPD, chronic obstructive pulmonary disease; CAD, coronary artery disease; HTN, hypertension; DM, diabetes mellitus; HIV, human immunodeficiency virus; PBS, phosphate-buffered saline; BAL, bronchoalveolar lavage.
b
Difference in mortality between the two groups (P = 0.37).